In focus
Latest feed
A New Dawn for Multiple Myeloma Patients: FDA Approves Bristol-Myers Squibb's Zenbexus
Elicio Therapeutics Navigates Q2 2026 with Strong Financing and Promising Clinical Signals
Unmasking Cancer's Paradox: How Self-Inflicted DNA Damage Fuels Tumor Growth
CRISPR Therapeutics: On the Cusp of a New Era in Medicine
Latest headlines
